We are live on ! Find out more
BCM

Beryl Capital Management Portfolio holdings

AUM $110M
1-Year Est. Return 317.92%
This Fund
S&P 500
This Quarter Est. Return
+45.86%
1 Year Est. Return
+317.92%
3 Year Est. Return
+5,124.04%
5 Year Est. Return
+10,319.28%
10 Year Est. Return
–
AUM
$82M
AUM Growth
-$100M
Cap. Flow
-$109M
Cap. Flow %
-132.71%
Top 10 Hldgs %
92.41%
Holding
35
New
13
Increased
2
Reduced
1
Closed
17

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$22.8M
2
FREE
Whole Earth Brands, Inc. Class A Common Stock
FREE
+$13.3M
3
M icon
Macy's
M
+$6.78M
4
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$5.76M
5
TAST
Carrols Restaurant Group, Inc.
TAST
+$4.82M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$34M
2
AYX
Alteryx Inc
AYX
+$26.6M
3
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$25.7M
4
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
+$21.6M
5
CMBT
CMB.TECH NV
CMBT
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 41.16%
2 Consumer Staples 18.36%
3 Consumer Discretionary 16.81%
4 Industrials 7.73%
5 Communication Services 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABP
26
DELISTED
Abpro Holdings
ABP
– –
-5,914
Closed -$1.88M
CFFS
27
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
– –
-682,830
Closed -$27.7K
HOLI
28
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
– –
-510,589
Closed -$13.5M
AYX
29
DELISTED
Alteryx Inc
AYX
– –
-563,299
Closed -$26.6M
SPLK
30
DELISTED
Splunk Inc
SPLK
– –
-222,921
Closed -$34M
ROVR
31
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
– –
-1,987,886
Closed -$21.6M
THRX
32
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-288,887
Closed -$1.17M
ORTX
33
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-1,561,499
Closed -$25.7M
BVH
34
DELISTED
Bluegreen Vacations Holding Corporation
BVH
– –
-14,778
Closed -$1.11M
CHS
35
DELISTED
Chicos FAS, Inc.
CHS
– –
-356,515
Closed -$2.7M
1
2

Similar funds

BCM
Bond Capital Management San Francisco, California $110M AUM 16.91% 1-Year Est. Return
NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
MCM
Masterton Capital Management New York $110M AUM 3.55% 1-Year Est. Return
PXPO
Peak XV Partners Operations Trianon, Mauritius $110M AUM 43.09% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $110M AUM 18.54% 1-Year Est. Return
SCP
Searchlight Capital Partners New York $109M AUM 43.33% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
BCM
Bretton Capital Management San Francisco, California $109M AUM 8.28% 1-Year Est. Return

Beryl Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Beryl Capital Management held 35 positions worth $82M, down 55% from $182M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Beryl Capital Management withdrew a net $109M in Q1 2024, closing 17 positions and reducing 1 holding. Its most notable exit was Splunk Inc, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Beryl Capital Management opened a new position in CATALENT, INC. worth $23.8M.

  • Beryl Capital Management's largest Q1 2024 buy was CATALENT, INC.: 420,836 shares worth $23.8M.
  • Beryl Capital Management added most to NeoGames S.A. Ordinary Shares in Q1 2024, an estimated $2.22M increase.
  • Beryl Capital Management's biggest Q1 2024 reduction was MRC Global, cutting an estimated $1.6M.
  • Beryl Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $34M.
  • Beryl Capital Management's ten largest holdings make up 92% of its $82M portfolio in Q1 2024.
  • Beryl Capital Management opened 13 new positions and closed 17 in Q1 2024.
  • Beryl Capital Management's portfolio value fell 55% quarter-over-quarter to $82M.

Based on Beryl Capital Management's 13F filing for Q1 2024, filed 15 May 2024.